Back
Lyell Immunopharma Vs. GlycoMimetics Industry Stock Comparison
Buy
59
LYEL
Lyell Immunopharma
Last Price:
2.74
Seasonality Move:
37.44%
Sell
24
GLYC
GlycoMimetics
Last Price:
0.30
Seasonality Move:
8.09%
Buy
59
Lyell Immunopharma (LYEL)
is a Buy
Is Lyell Immunopharma a Buy, Sell or Hold?
- The current Lyell Immunopharma [LYEL] share price is $2.74. The Score for LYEL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- LYEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
24
GlycoMimetics (GLYC)
is a Sell
Is GlycoMimetics a Buy, Sell or Hold?
- The current GlycoMimetics [GLYC] share price is $0.30. The Score for GLYC is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- GLYC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LYEL Stock Price Chart
What is Lyell Immunopharma's stock price today?
-
The Lyell Immunopharma share price today is $2.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
GLYC Stock Price Chart
What is GlycoMimetics's stock price today?
-
The GlycoMimetics share price today is $0.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLYC is experiencing slight buying pressure.
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 60.07 | Buy |
| Chaikin Money Flow: | -575819 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.26 - 2.58) | Buy |
| Bollinger Bands (100): | (1.93 - 2.53) | Buy |
GLYC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.55 | Sell |
| Relative Strength Index (14 RSI): | 21.98 | Sell |
| Chaikin Money Flow: | 560894 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.44 - 2.04) | Sell |
| Bollinger Bands (100): | (1.64 - 3.36) | Sell |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.59 | Buy |
| 20-day SMA: | 2.44 | Buy |
| 50-day SMA: | 2.32 | Buy |
| 200-day SMA: | 2.06 | Buy |
| 8-day EMA: | 2.61 | Buy |
| 20-day EMA: | 2.49 | Buy |
| 50-day EMA: | 2.37 | Buy |
| 200-day EMA: | 2.36 | Buy |
GLYC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.28 | Buy |
| 20-day SMA: | 1.01 | Sell |
| 50-day SMA: | 2 | Sell |
| 200-day SMA: | 2 | Sell |
| 8-day EMA: | 0.4 | Sell |
| 20-day EMA: | 0.92 | Sell |
| 50-day EMA: | 1.67 | Sell |
| 200-day EMA: | 2.04 | Sell |
Lyell Immunopharma Earnings Growth & LYEL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.04 per share.
GlycoMimetics Earnings Growth & GLYC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
Lyell Immunopharma Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
GlycoMimetics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||